Rab25 expression is associated with the therapeutic response to epidermal growth factor receptor (EGFR)-TKIs, such as erlotinib, in non-small cell lung cancer (NSCLC) [60]. The gene discussed is RAB25; the disease is non-small cell lung carcinoma.